NEUROCRINE BIOSCIENCES, INC. (NBIX) Operating margin 2016–2025
NEUROCRINE BIOSCIENCES, INC. (NBIX) operating margin by fiscal year — reported operating income divided by reported revenue.
21.6%FY2025 · since FY2016: -982.5% → 21.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 21.6% | -2.6 pp |
| FY2024 | 24.2% | +10.9 pp |
| FY2023 | 13.3% | -3.4 pp |
| FY2022 | 16.7% | +7.7 pp |
| FY2021 | 9.0% | -6.5 pp |
| FY2020 | 15.6% | +6.4 pp |
| FY2019 | 9.2% | +1.0 pp |
| FY2018 | 8.2% | +89.4 pp |
| FY2017 | -81.3% | +901.2 pp |
| FY2016 | -982.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice